NO20074850L - Oftalmologiske sammensetninger og anvendelse derav - Google Patents

Oftalmologiske sammensetninger og anvendelse derav

Info

Publication number
NO20074850L
NO20074850L NO20074850A NO20074850A NO20074850L NO 20074850 L NO20074850 L NO 20074850L NO 20074850 A NO20074850 A NO 20074850A NO 20074850 A NO20074850 A NO 20074850A NO 20074850 L NO20074850 L NO 20074850L
Authority
NO
Norway
Prior art keywords
ophthalmological compositions
eye before
agent
ophthalmological
compositions
Prior art date
Application number
NO20074850A
Other languages
English (en)
Other versions
NO339793B1 (no
Inventor
Walid Khatib
Original Assignee
Lab Thea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab Thea filed Critical Lab Thea
Publication of NO20074850L publication Critical patent/NO20074850L/no
Publication of NO339793B1 publication Critical patent/NO339793B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Neurology (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Oppfinnelsen angår en farmasøytisk sammensetning kjennetegnet ved at den inneholder en kombinasjon av et parasympatolytisk middel, et sympatomimetisk middel og en lokal anestetisk. En slik sammensetning kan bli injisert inn i det fioranliggende kammeret av øyet fiør en katarakt operasjon eller på øyet fiør laser behandling.
NO20074850A 2005-03-09 2007-09-24 Oftalmologiske sammensetninger og anvendelse derav NO339793B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0502357A FR2882930B1 (fr) 2005-03-09 2005-03-09 Nouvelles compositions ophtalmologiques et leur mode d'utilisation
PCT/FR2006/000528 WO2006095095A1 (fr) 2005-03-09 2006-03-09 Compositions ophtalmologiques et leur mode d’utilisation

Publications (2)

Publication Number Publication Date
NO20074850L true NO20074850L (no) 2007-09-24
NO339793B1 NO339793B1 (no) 2017-01-30

Family

ID=35058756

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20074850A NO339793B1 (no) 2005-03-09 2007-09-24 Oftalmologiske sammensetninger og anvendelse derav
NO2017008C NO2017008I1 (no) 2005-03-09 2017-03-24 Tropikamid, fenylefrinhydroklorid og lidokainhydroklorid

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2017008C NO2017008I1 (no) 2005-03-09 2017-03-24 Tropikamid, fenylefrinhydroklorid og lidokainhydroklorid

Country Status (27)

Country Link
US (2) US20080194649A1 (no)
EP (1) EP1858481B1 (no)
JP (1) JP2008532985A (no)
KR (1) KR20070111501A (no)
CN (1) CN101151018A (no)
BE (1) BE2019C013I2 (no)
CA (1) CA2598503C (no)
CY (2) CY1121865T1 (no)
DK (1) DK1858481T3 (no)
ES (1) ES2728071T3 (no)
FR (2) FR2882930B1 (no)
HR (1) HRP20191044T1 (no)
HU (1) HUE043668T2 (no)
IL (1) IL185197A0 (no)
LT (2) LT1858481T (no)
LU (1) LUC00136I2 (no)
MA (1) MA29269B1 (no)
MX (1) MX2007010295A (no)
NL (1) NL301017I2 (no)
NO (2) NO339793B1 (no)
PL (1) PL1858481T3 (no)
PT (1) PT1858481T (no)
RU (1) RU2392925C2 (no)
SI (1) SI1858481T1 (no)
TN (1) TNSN07343A1 (no)
TR (1) TR201908487T4 (no)
WO (1) WO2006095095A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8602959B1 (en) * 2010-05-21 2013-12-10 Robert Park Methods and devices for delivery of radiation to the posterior portion of the eye
BR112013021048A2 (pt) * 2011-02-18 2016-10-18 M S Appasmy Associates composição oftálmica para permitir dilatação de pupilas
ITPA20110004A1 (it) * 2011-02-23 2012-08-24 Francesco Paolo Montalto Iniezione intracamerulare per anestesia e dilatazione pupillare (midriasi).
CN103159672A (zh) * 2012-07-16 2013-06-19 湖南尔文生物科技有限公司 一种托品酰胺的制备方法
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
RU2525512C1 (ru) * 2013-03-28 2014-08-20 федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ медикаментозного расширения ригидного зрачка перед проведением факоэмульсификации
US20210346318A1 (en) * 2013-10-03 2021-11-11 Harrow Ip, Llc Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
US10993921B2 (en) * 2013-10-03 2021-05-04 Harrow Ip, Llc Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
CN105213418B (zh) * 2015-11-11 2019-01-22 中国人民解放军第四军医大学 一种眼科术前用复方滴眼液及其制备方法
AU2017315757A1 (en) 2016-08-25 2019-03-07 Harrow Ip, Llc Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
RU2649534C1 (ru) * 2017-05-10 2018-04-03 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Способ анестезии при факоэмульсификации катаракты
RU2662423C1 (ru) * 2017-07-26 2018-07-25 Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ проведения обезболивания при выполнении витреоретинальных операций
SG11202110423UA (en) * 2019-03-26 2021-10-28 Martin Uram Anesthetic composition and method of anesthetizing the eye

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3026323A (en) * 1960-03-22 1962-03-20 Rubin J Schacter Salts of tribasic acids
US4738851A (en) * 1985-09-27 1988-04-19 University Of Iowa Research Foundation, Inc. Controlled release ophthalmic gel formulation
JPH0780760B2 (ja) * 1986-07-28 1995-08-30 ライオン株式会社 安定化されたフエニレフリン系液剤
JP3066561B2 (ja) * 1993-10-07 2000-07-17 武田薬品工業株式会社 近視予防・治療剤
US5686414A (en) * 1995-11-14 1997-11-11 Xoma Corporation Methods of treating conditions associated with corneal transplantation
US5779661A (en) * 1995-12-11 1998-07-14 Physion, S.R.L. Method of treating dysfunctional bladder syndromes by electromotive drug administration
US6319240B1 (en) * 1999-05-25 2001-11-20 Iomed, Inc. Methods and apparatus for ocular iontophoresis
CA2391448A1 (en) * 1999-11-12 2001-05-17 Leo Rubin Use of vasoactive intestinal peptides and kits therefor
US6218428B1 (en) * 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
JP4150846B2 (ja) * 2001-03-28 2008-09-17 参天製薬株式会社 ステロイドを有効成分とする網脈絡膜疾患治療剤
RU2183115C1 (ru) * 2001-06-29 2002-06-10 Государственное унитарное предприятие Межбольничная аптека Медицинского центра Управления делами Президента Российской Федерации Фармацевтическая композиция, обладающая спазмолитическим и анальгезирующим действием
US20040013729A1 (en) * 2002-07-18 2004-01-22 Buono Lawrence M. Single-drop multiple-agent composition for topical delivery to the eye
PT1534313E (pt) * 2002-07-30 2013-01-25 Omeros Corp Soluções e método de irrigação oftalmológica

Also Published As

Publication number Publication date
BE2019C013I2 (no) 2025-12-03
SI1858481T1 (sl) 2019-08-30
US20080194649A1 (en) 2008-08-14
FR2882930A1 (fr) 2006-09-15
CA2598503A1 (fr) 2006-09-14
CY2019042I1 (el) 2020-05-29
EP1858481A1 (fr) 2007-11-28
CY2019042I2 (el) 2020-05-29
MX2007010295A (es) 2007-12-11
CY1121865T1 (el) 2020-05-29
PL1858481T3 (pl) 2019-09-30
US20120220637A1 (en) 2012-08-30
CA2598503C (fr) 2014-01-28
HRP20191044T1 (hr) 2019-09-06
FR19C1066I2 (fr) 2021-01-08
LT1858481T (lt) 2019-07-10
US9289399B2 (en) 2016-03-22
NO2017008I2 (no) 2017-03-24
DK1858481T3 (da) 2019-06-03
NO2017008I1 (no) 2017-03-24
BRPI0607416A2 (pt) 2009-09-08
LUC00136I2 (no) 2021-02-12
IL185197A0 (en) 2008-01-06
FR2882930B1 (fr) 2009-03-27
LTPA2019017I1 (lt) 2019-12-10
TNSN07343A1 (fr) 2008-12-31
NO339793B1 (no) 2017-01-30
HUE043668T2 (hu) 2019-08-28
KR20070111501A (ko) 2007-11-21
RU2007137115A (ru) 2009-04-20
WO2006095095A1 (fr) 2006-09-14
TR201908487T4 (tr) 2019-07-22
RU2392925C2 (ru) 2010-06-27
NL301017I1 (nl) 2019-11-06
ES2728071T3 (es) 2019-10-22
NL301017I2 (nl) 2020-04-30
LUC00136I1 (no) 2019-11-04
PT1858481T (pt) 2019-06-14
MA29269B1 (fr) 2008-02-01
CN101151018A (zh) 2008-03-26
FR19C1066I1 (fr) 2019-12-20
EP1858481B1 (fr) 2019-05-08
JP2008532985A (ja) 2008-08-21

Similar Documents

Publication Publication Date Title
NO20074850L (no) Oftalmologiske sammensetninger og anvendelse derav
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
BRPI0909749A2 (pt) uso de fotoiniciador para fabrico de medicamento para tratamento do ceratocone, da ectasia e fortalecimento da córnea
AR109605A2 (es) Método para tratar enfermedades vasculares periféricas, composición y utilización
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
CO6331425A2 (es) Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida
BRPI0508540B8 (pt) composto, composição farmacêutica, e, uso de um composto
ATE428401T1 (de) Suspensionsformulierungen mit einem aktiven wirkstoff, einem poloxamer- oder meroxapol-tensid und einem glycol und ihre verwendung zur herstellung eines medikaments zur behandlung von augenkrankheiten
MX2017010287A (es) Composiciones farmaceuticas que comprenden n-(3,5-dimetoxifenil)-n '-(1-metiletil)-n-[3-(1-metil-1h-pirazol-4-il)quinoxalin-6-il]eta no-1,2-diamina.
MX351152B (es) Compstatina y analogos de la misma para tratar trastornos oculares.
DE60336664D1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
BRPI0520588B8 (pt) uso de composições farmacêuticas para o tratamento de doenças do ouvido interno
ECSP088239A (es) Composición de liberación de fármaco sostenida
CR20210376A (es) COMPUESTOS Y USO PARA EL TRATAMIENTO DE LA DEFICIENCIA DE a1-ANTITRIPSINA
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
EA200870526A1 (ru) Композиция, включающая по меньшей мере один высший алифатический спирт и экстракт griffonia simplicifolia
WO2008013986A3 (en) Compositions and methods for treating or preventing ophthalmic light toxicity
NO20066005L (no) Injiserbar farmasoytisk suspensjon omfattende posaconazol
NO20076405L (no) Anvendelse av 24-nor-UDCA
AR048439A1 (es) Composiciones farmaceuticas y metodos para tratar la infeccion por vih
MXPA06012780A (es) Polimeros a base de acrilico y celulosa y el uso de los mismos para el tratamiento de enfermedades infecciosas.
BRPI0510778A (pt) composição farmacêutica, processo para a preparação da mesma, método para o tratamento de rinite, e, uso de uma composição
ATE508711T1 (de) Vorgeformter intrastromaler hornhauteinsatz für hornhautanomalien oder -dystrophien
DE602006003438D1 (de) Ophthalmische suspension aus einem ophthalmischen arzneimittel, einem poloxamin und glykol-tonizitätsanpassenden mittel, verwendung der zusammensetzung zur herstellung eines medikaments zur behandlung von augenerkrankungen
CL2009000986A1 (es) Uso de inhibidores de pai-1 para la p0reparacion de un medicamento util en el tratamiento de hipertension ocular y glaucoma

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: TROPIKAMID, FENYLEFRINHYDROKLORID OG LIDOKAINHYDROKLORID

Spc suppl protection certif: 2017008

Filing date: 20170324

SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: TROPIKAMID, FENYLEFRINHYDROKLORID OG LIDOKAINHYDROKLORID; NO MARKETING AUTHORISATION 2015.07.14 , NO , 14-10062 , MYDANE

Spc suppl protection certif: 2017008

Filing date: 20170324

Extension date: 20300714